LARK Q1 2026 Earnings EPS of 083 Amidst Stock Decline AIM ImmunoTech Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment UVSP Q1 2026 Earnings Strong EPS Beat Amidst Modest Stock Movement ROIV Q1 2026 Earnings WiderThanExpected Loss Highlights PreRevenue Pipeline Costs Septerna Inc Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Century Communities Q1 2026 Earnings EPS Surges 68 Above Estimates Shares Edge Lower